Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19
- PMID: 37830952
- DOI: 10.1097/QCO.0000000000000967
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19
Abstract
Purpose of review: Respiratory syncytial virus (RSV) remains a leading cause of mortality and morbidity worldwide. RSV seasonality was disrupted by COVID-19-associated nonpharmaceutical interventions (NPIs). We review RSV seasonality, molecular epidemiology, clinical manifestations, and community awareness to inform future prevention strategies.
Recent findings: An initial reduction of RSV disease observed with NPIs, and subsequent global resurgence was associated with a collapse in genetic diversity. A lack of immunity is suggested to have contributed to the resurgence of RSV cases experienced post COVID-19. The median age of children admitted with RSV increased during the resurgence, likely secondary to the expanded cohort of RSV-immune naive children. The pandemic also played a role in increased community awareness, which can be utilized as part of a coordinated public health effort to introduce prevention strategies. Further education on signs and symptoms of RSV is still required.
Summary: mAbs and maternal vaccines targeting RSV have the potential to reduce paediatric morbidity, however this new era of RSV prevention will require ongoing research to facilitate community awareness and engagement, and better respiratory surveillance. Tackling the global burden of RSV will require a coordinated effort and measures to ensure access and affordability of new prevention strategies.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Ramilo O, Rodriguez-Fernandez R, Mejias A. Respiratory syncytial virus infection: old challenges and new approaches. J Infect Dis 2023; 228:4–7.
-
- Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 2022; 399:2047–2064.
-
- GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet 2021; 398:870–905.
-
- Thongpan I, Vongpunsawad S, Poovorawan Y. Respiratory syncytial virus infection trend is associated with meteorological factors. Sci Rep 2020; 10:10931.
-
- Guerrero-Del-Cueto F, Ramos-Fernandez JM, Leiva-Gea I, et al. Bronchiolitis before and after the SARS-CoV-2 pandemic: twelve years of experience in a Spanish paediatric hospital. Pediatr Pulmonol 2023; 58:1201–1209.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials